A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency

计划入组 14 人 · 首次发布于 2017 年 12 月 20 日

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

计划入组 16 人 · 首次发布于 2015 年 7 月 2 日

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)

计划入组 20 人 · 首次发布于 2010 年 3 月 24 日

Pegylated Recombinant Human Arginase I

Pegzilarginase(Loargys)

exosome-mediated arginase 1 enzyme replacement therapy (Stealth-X, arginase 1 deficiency)

Universitetet i Oslo

Norway

I-SHOU UNIVERSITY

Taiwan

i-SENS, Inc.

South Korea

Ravicti Receives Regulatory Approval in Saudi Arabia, Qatar, and Kuwait for Urea Cycle Disorders

Aeglea BioTherapeutics Submits BLA for Pegzilarginase as First Potential Treatment for Arginase 1 Deficiency

Engineered Microparticles Repolarize Tumor-Associated Macrophages and Inhibit Colorectal Cancer Progression